Adaptive Biotechnologies Corporation (ADPT) vs Edgewise Therapeutics, Inc. (EWTX)
A side-by-side comparison of Adaptive Biotechnologies Corporation and Edgewise Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADPT
Adaptive Biotechnologies Corporation
$30.22HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
EWTX
Edgewise Therapeutics, Inc.
$40.68HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — ADPT vs EWTX
growth of $100 · dividends reinvested · last 6yADPT -21.8% (-4.0%/yr)EWTX +34.3% (+5.0%/yr)EWTX compounded faster over this window
ADPT EWTX
ADPT vs EWTX: by the numbers
- •ADPT is the larger company ($4.84B vs $4.38B market cap).
- •Both run net losses; EWTX's is the smaller (0.00% vs -20.73% net margin).
Metrics side by side
Valuation
| Metric | ADPT | EWTX |
|---|---|---|
| P/S ratio | 15.70 | N/A |
| P/B ratio | 33.84 | 9.77 |
Profitability
| Metric | ADPT | EWTX |
|---|---|---|
| Gross margin | 75.44% | 0.00% |
| Operating margin | -20.62% | 0.00% |
| Net margin | -20.73% | 0.00% |
| ROE | -44.68% | -44.02% |
| ROIC | -6.67% | -48.57% |
Growth (annualized)
| Metric | ADPT | EWTX |
|---|---|---|
| Revenue CAGR (5Y) | 18.22% | N/A |
| Total return CAGR (5Y) | -1.77% | 16.95% |
Frequently asked
- How have ADPT and EWTX total returns compared?
- Over the past 5 years, ADPT delivered -1.77% and EWTX delivered 16.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Adaptive Biotechnologies ROEEdgewise Therapeutics ROEAdaptive Biotechnologies operating marginEdgewise Therapeutics operating marginAdaptive Biotechnologies revenue growthEdgewise Therapeutics revenue growthAdaptive Biotechnologies free cash flowEdgewise Therapeutics free cash flow
Adaptive Biotechnologies & Edgewise Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.